In Vivo Bioequivalence and In Vitro Similarity Factor (f2) for Dissolution Profile Comparisons of Extended Release Formulations: How and When Do They Match?

2011 
Purpose To investigate how likely two extended release formulations are to be bioequivalent when they demonstrate f2 similarity.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    17
    References
    36
    Citations
    NaN
    KQI
    []